Company profilePharmaceutical#717 of 1,318 in Pakistan✓ No DRAP alerts

EXCEL HEALTHCARE LABORATORIES (PVT.) LTD.

Pharmaceutical company · 13 brands · 13 molecules

Ranked #12 of 20 companies in Cancer

13 registered products 13 pharmaceutical brands 13 distinct molecules 0 DRAP alerts

Company overview

13
registered products
13
pharmaceutical brands
13
distinct molecules
7
therapeutic classes
0
DRAP alerts

EXCEL HEALTHCARE LABORATORIES (PVT.) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 13 product registrations across 13 distinct molecules. Its portfolio is concentrated in Cancer and Hormone Regulators. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by EXCEL

6 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Antimycotics Systemic Use 1
Hormone Regulators 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
1
not revised in 2+ years
2024
oldest approval year
20241
Longest without revision

Top molecules by brand count

Letrozole2 brands
Menotropin1 brand
Omeprazole1 brand
Conjugated Estrogen ...... 0.3 Mg1 brand

Therapeutic classes

Cancer · 1Hormone Regulators · 1Progestogen · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Oestrogens · 1Antimycotics Systemic Use · 1Endocrine Hormone Therapy · 1

Conditions treated

Oncology · 1Hormonal Therapy · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official2 products · Rs 766.93 – Rs 766.93
DVAGO4 products · Rs 199 – Rs 3,226.1
Servaid2 products · Rs 1,801.8 – Rs 7,527
Median across source: Rs 1,547.65

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

GALAXY PHARMA (PVT) LTD.7 shared molecules
LEO/ZAMZAM2 shared molecules
ALLMED LABORATORIES2 shared molecules
BIO LABS (PVT) LTD.2 shared molecules
SEARLE PAKISTAN (PVT.) LTD.2 shared molecules
Albro Pharmaceuticals2 shared molecules
PANACEA PHARMACEUTICALS2 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GALAXY PHARMA (PVT) LTD. holds 4 molecules not in this portfolio
Chorionic GonadotrophinChorionic Gonadotrophin (Human Chorionic GonadotrophinGonadotropinHcg)
GENOME PHARMACEUTICALS (PVT) LTD holds 110 molecules not in this portfolio
AcitretinAmlodipineAnastrazoleAnastrozoleAprepitantArtemether
LEO/ZAMZAM holds 6 molecules not in this portfolio
AlfacalcidolBetamethasoneCalcipotriolFusidic AcidFusidic Acid InjHydrocortisone

Get the full profile for EXCEL

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.